insulin aspart vs octreotide
According to this portal's Publishing Organization, this page was last reviewed in August 2026 against our methodology. Figures and extracts on this site, including tables above 1,000 rows when the corpus is that large, are the publisher's responsibility.
Side-by-side comparison of insulin aspart and octreotide. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
moderate Known Drug Interaction
Drugs That May Increase the Risk of Hypoglycemia Drugs: Antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analog (e.g., octreotide), and sulfonamide antibiotics. • Drugs that may increase the risk of hypoglycemia: antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analog (e.g., octreotide), and...
NovoLog, Fiasp
Sandostatin
NovoLog (insulin aspart) is a rapid-acting insulin that helps control blood sugar in people with diabetes. It works quickly to lower blood sugar levels after meals.
Octreotide is a drug that mimics a natural hormone in your body. It is used to treat certain conditions caused by too much of certain hormones.
NovoLog is used to improve blood sugar control in adults and children with diabetes. Diabetes is a condition where your body doesn't make enough insulin or can't use insulin properly, leading to high blood sugar. This medicine helps to lower your blood sugar levels.
Octreotide is used to lower growth hormone and insulin-like growth factor-1 in people with acromegaly who haven't responded to other treatments. It also helps manage severe diarrhea and flushing caused by carcinoid tumors. Additionally, it can treat watery diarrhea caused by VIPomas (tumors that release vasoactive intestinal peptide).
NovoLog is a man-made form of insulin that works like the insulin your body naturally makes. It helps sugar (glucose) move from your blood into your cells, where it can be used for energy. This lowers the amount of sugar in your blood.
This medicine works by mimicking somatostatin, a natural hormone in your body. It reduces the amount of certain hormones, like growth hormone, that your body makes. By doing this, it helps control the symptoms caused by having too much of these hormones.
- • Headache
- • Accidental injury
- • Nausea
- • Diarrhea
- • Low blood sugar
- • Gallbladder problems
- • Slow heart rate
- • Diarrhea
- • Loose stools
- • Nausea
- Blood Glucose Increased 10,424
- Nausea 3,724
- Blood Glucose Decreased 3,344
- Fatigue 2,664
- Dyspnoea 2,553
- Diarrhoea 526
- Death 375
- Nausea 345
- Fatigue 305
- Malignant Neoplasm Progression 235
Never share your NovoLog FlexPen, FlexTouch, PenFill cartridge, or PenFill cartridge device with anyone else, even if the needle is changed. Sharing insulin pens or cartridges can spread blood-borne diseases. Changes in your insulin regimen should be made carefully under medical supervision. Low blood sugar can be life-threatening. Monitor your blood sugar regularly. Fluid retention and heart failure can occur if you take NovoLog with thiazolidinediones (TZDs).
Octreotide can cause heart problems, including a higher risk of certain types of heart block. Your doctor may monitor your heart if you receive this drug intravenously. It can also cause gallbladder problems, high or low blood sugar, and thyroid issues. Tell your doctor right away if you notice new or worsening symptoms.
Tell your doctor if you are pregnant or plan to become pregnant. Good control of diabetes is important during pregnancy for both you and your baby. Discuss the best way to manage your blood sugar with your doctor.
There is limited information about the safety of octreotide during pregnancy. Talk to your doctor if you are pregnant or plan to become pregnant. It is not known if octreotide passes into breast milk, so talk to your doctor about breastfeeding while using this medicine.
Also Compare, Nearby Drugs
Compare insulin aspart with
How to Read This insulin aspart vs octreotide Comparison
insulin aspart is classified in the Rapid-Acting Insulin drug class, while octreotide sits within the Somatostatin Analog class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, insulin aspart has 22,709 submissions while octreotide has 1,786. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known moderate interaction flagged in FDA labeling, attributed to octreotide can change how your body handles sugar and may increase the blood-sugar-lowering effects of insulin.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for insulin aspart or octreotide.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.